Background: Early loss of neurites followed by delayed damage of neuronal somata is a feature of several neurodegenerative diseases. Death by apoptosis would ensure the rapid removal of injured neurons, whereas conditions that prevent apoptosis may facilitate the persistence of damaged cells and favor inflammation and disease progression. Materials and Methods: Cultures of cerebellar granule cells (CGC) were treated with microtubule disrupting agents. These compounds induced an early degeneration of neurites followed by apoptotic destruction of neuronal somata. The fate of injured neurons was followed after co-exposure to caspase inhibitors or agents that decrease intracellular ATP (deoxyglucose, S-nitrosoglutathione, l-methyl-4-phenylpyridinium). We examined the implications of energy loss for caspase activation, exposure of phagocytosis markers, and long-term persistence of damaged cells. Results: In CGC exposed to colchicine or nocodazole,
Introduction
Apoptosis is a mode of cell death by which superfluous or dysfunctional cells are removed from tissues. However, an increased rate of apoptosis may also be a component of neurodegenerative diseases (1, 2) . Frequently, the apoptotic execution phase is characterized by activation of caspases that cleave a defined subset of cellular proteins (3) . This leads to characteristic morphological changes such as nuclear condensation (4) , and to the display of phagocytosis recognition molecules on the cell surface (5, 6) . The latter process is responsible for the swift removal of dying cells before the plasma membrane lyses (7) . Rapid and efficient phagocytosis may also explain the low frequency of apoptotic cells, which can be observed in neurodegenerative disorders (1, 8, 9) . In fact, in Alzheimer's disease, the persistence of dysfunctional (10) and degenerating neurons is more conspicuous than apoptosis (1 1). Neurons initially undergo cytoskeletal changes and lose dendritic projections, until only the cell bodies seem to be left at late stages. Similar changes are common to several axonopathies (11) .
The persistence of neuronal remnants in such conditions may be explained by a block or low efficiency of the mechanisms that lead to the activation of the protease families (primarily caspases) involved in exposure of recognition molecules. This would result in a defective disposal of dying cells (5) (6) (7) . It has been shown that the activation of caspases by the cytochrome-c and Apaf-1-containing apoptosome requires dATP or ATP (12, 13) . Thus, severe disorders in energy metabolism may preclude the activation of caspases. In agreement with this is the finding that apoptosis of tumor cells is entirely suppressed when cellular ATP is depleted by 50- 60% (14, 15) . Also, in neurons, there is circumstancial evidence for a similar control of cell death by ATP: in cultures exposed to glutamate (16) or 1 -methyl-4-phenylpyridinium (MPP+) (17) , only the neuronal subpopulation that maintains an adequate cellular energy charge dies with apoptotic features.
Thus, we designed this study to test whether manipulation of neuronal ATP levels by drugs or mediators, which affect energy metabolism, would compromise the execution and occurrence of cell death following an initial axonal degeneration. Cell death was triggered in cerebellar granule neurons (CGC) by the cytoskeletal disrupting agents colchicine or nocodazole, which are known to trigger caspase activation (18) and delayed neuronal apoptosis both in vivo and in vitro (19, 20) . Finally, we examined the long-term fate of neurons that were treated with microtubule poisons but were incapable of executing apoptosis because of caspase inhibition.
Materials and Methods
Materials SYTOX and H-33342 were obtained from Molecular Probes (Eugene, OR). The caspase substrate, N-acetyl-Asp-Glu-Val-aspartyl-aminotrifluoromethylcoumarine (DEVD-afc), 1-methyl-4-phenyl-pyridinium (MPP+), cyclosporine A (CsA), and S-nitrosoglutathione (GSNO) were obtained from Biomol (Hamburg, Germany), and (+)-5-methyl-10,1 1 -dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine (MK801) came from RBI (Biotrend Chemikalien GmbH, Koln, Germany). Caspase inhibitors N-acetyl-Asp-Glu-Val-Aspaldehyde (DEVD-CHO), N-benzyloxycarbonylVal-Ala-aspartyl-fluoromethylketone (zVAD-fmk), N-acetly-Tyr-Val-Ala-aspartyl-chloromethylketone (YVAD-cmk), and N-benzyloxycarbonylaspartyl-2,6-dichlorobenzoyloxymethylketone (ZD-cbk) were obtained from Bachem Biochemica GmbH (Heidelberg, Germany). DEVD Cell Culture Murine CGC were chosen for these studies and isolated as described previously (21) . These cells form a highly complex axodendritic network consisting of over 95% of one single neuronal type. Dissociated neurons were plated on 100 ,ug/ml (250 ,ug/ml for glass surfaces) poly-L-lysine (MW >300 kDa) coated dishes at a density of about 0.25 x 106 cells/cm2 (800,000 cells/ml; 500 IlI/well, 24-well plate) and cultured in Eagle's basal medium (BME, Gibco) supplemented with 10% heat inactivated fetal calf serum (FC S), 20 mM KCI, 2 mM L-glutamine and penicillinstreptomycin, and cytosine arabinoside (added 48 hr after plating). Neurons were used without further medium changes after 8 days in vitro (DIV). At that time, the residual glucose concentration in the medium was about 1 mM. The cultures were exposed to colchicine or nocodazol in their original medium for most experiments in the presence of 2 ,uM MK801 and 2 MM Mg2+ to prevent NMDA receptor activation and excitotoxicity (22) . All inhibitors were added 30 30 min before colchicine exposure and remained present throughout the experiment. To restore ATP, the culture medium was supplemented with glucose (0 or 10 mM) 3 hr before exposure to colchicine. In this setup, the ATP depletors were added 8 hr after colchicine addition. Measurements of ATP and of protein synthesis (leucine-incorporation) were performed after 9.5 hr. Apoptosis and caspase activity were quantitated after 18 hr. In some delayed ATP repletion experiments, colchicine-treated CGC were kept ATP-deprived by deoxyglucose for 20 hr. After that time glucose (10 mM) was added and nuclear condensation was followed over the following 4 (25) . Briefly, 3H-leucine (2 ,Ci) was added to CGC in a volume of 10 ,ul, in 24-well plates (150 MBq/ml final). After 90 min incubation, the medium was removed. Cells were washed three times with ice-cold trichloroacetic acid (TCA, 10%) and dried with methanol (-20°C). The cell layers were lysed (0.3 M NaOH, 1% SDS) for 12 hr at 37°C, and incorporated radioactivity was detected by (3-scintillation counting.
Visualization of Phosphatidylserine Translocation
Surface phosphatidylserine expression of cultures grown on glass-bottomed culture dishes was analysed by annexin V staining and confocal microscopy (TCS-4D UV/VIS confocal scanning system; Leica AG and Leica Lasertechnik) as described previously (18) .
Enzymatic Assays Caspase-3-like activity (measured by DEVD-afc cleavage) was assayed essentially as described before (26, 27) . CGC were lysed in 25 mM HEPES, 5 mM MgCl2, 1 ImM EGTA, 0.5% Triton X-100, 1 jig/ml leupeptin, 1 jig/ml pepstatin, 1 ,ug/ml aprotinin, and 1 mM PEFA-block, pH 7.5. The fluorimetric assay was carried out in microtiter plates with a substrate concentration of 40 ,uM and a total protein amount of 5 ,g. Glucose concentrations in the medium were determined by the hexokinase/ glucose dehydrogenase method using a commer-cial kit (Sigma). ATP was measured luminometrically after lysis of cells in ATP-releasing agent (Sigma) as described earlier (14, 22 40 ,uM leupeptin, 10 ,g/ml antipain, 5 ,g/ml pepstatin]. Protein was determined using the bicinchoninic acid method (Bio-Rad, Muinchen, Germany).
Proteins To examine whether caspase activation by colchicine and nocodazol was entirely due to microtubule depolymerization, we used taxol, a drug that stabilizes microtubules and antagonizes the effects of colchicine (20) and nocodazole. Treatment of CGC with 1 ,uM taxol up to 3 hr after colchicine addition prevented both microtubule breakdown and the increase in caspase activity (Fig. 2) 3A ). Complete protection from apoptosis by zVAD-fmk was still observed when the inhibitor was added up to 10 hr after colchicine. In contrast, YVAD-cmk, which is more specific for caspases related to caspase-1, did not prevent apoptosis at concentrations up to 100 ,uM (Fig. 3A) .
Caspase activation was also tested by analyzing fodrin proteolysis. Fodrin was cleaved to 150 and 120 kDa fragments after exposure of CGC to colchicine (or nocodazol, not shown), and the proteolysis to the 120 kDa fragment [which is a specific marker for caspase-3 activity (29) ] was inhibited by the caspase inhibitors that protected from apoptosis (Fig. 3B) . The extent of inhibition of fodrin cleavage with different inhibitors correlated with the protective effect exerted by these agents on apoptosis. This finding further confirms that caspase-3-like caspases are the principal executors of neuronal apoptosis induced by microtubule breakdown. Pretreatment of CGC with DG abolished neuronal apoptosis triggered by microtubule disruption (Fig. 4B) . Even delayed addition of DG up to 10 hr after colchicine exposure still prevented apoptosis. Thus, ATP-dependent steps were crucial after this time. GSNO and MPP+ also prevented colchicine-induced apoptosis to a similar extent (Fig. 4B) .
We tested whether ATP depletion would prevent apoptosis in another paradigm of neuro- nal apoptosis. One of the best-characterized models in CGC is withdrawal of potassium (31) . In this setup, apoptosis was significantly reduced by deoxyglucose when the salt solution used for the withdrawal situation contained low glucose concentrations (0.5 mM), but not after supplementation with the normally used high glucose concentrations (10 mM) (Fig. 4B) .
Restoration of Caspase Activity and Cell Death by Repletion of Intracellular ATP
The ATP depletion elicited by DG, GSNO, and MPP+ was then antagonized by increasing the glucose concentration in the culture medium. Supplementation of the medium with 10 mM glucose bypassed the effects of DG and restored cellular ATP levels as well as colchicine-triggered caspase activity and apoptotic death (Fig. 5A) . As a corollary, the prevention of procaspase-3 processing by DG was also reversed by glucose (Fig. 5B ).
Glucose may be metabolized glycolytically to generate ATP. Alternatively, it may be channeled into the pentose-phosphate shunt that provides cells with NADPH and therefore increases their capacity to cope with oxidative stress. To get clarity on the metabolic role of glucose, we also used alternative energy substrates that are not metabolized in the pentosephosphate shunt. All substances that repleted ATP [ 10 mM glycerol (6 5 %), 20 mM succinate (65%), 5 mM glutamine (60%)] restored the ability of CGC to undergo apoptosis (55%, 65%, 50%, respectively, compared to restoration with glucose). Nonrepleting substances (creatine, fructose, 1 ,6-fructose-bisphosphate) had no effect on apoptosis.
Glutathione measurements showed that the cellular content of this redox buffer is not significantly altered by incubation with DG or DG plus colchicine for up to 14 hr. This further suggests that DG acts by ATP depletion and not by increasing oxidative stress in neurons. We also found that the capacity of cells to initiate apoptosis is retained in CGC for at least 20 hr after incubation with DG and colchicine: when glucose was added to cultures after that time, apoptosis started immediately, reaching 27% after 60 min and 72% after 4 hr. Thus, it seems unlikely that caspases had been inactivated, e.g., by oxidative or nitrative stess.
Since CGC have a very high glycolytic capacity (32), increased glucose concentrations also compensated the ATP depletion affected by the mitochondrial inhibitors MPP+ and GSNO. As in the case of DG, caspase activity, caspase-3 processing, and the rate of apoptosis were modulated in parallel (Fig. 6) .
When we examined the morphological features of degenerating neurons after exposure to colchicine, we noticed that ATP depletion (Fig. 5C ) prevented all the features of neuronal demise, which were also precluded by the caspase inhibitors. The most relevant finding was that treatment with DG prevented colchicinetriggered exposure of phosphatidylserine (PS) on the cell surface, a key factor for recognition of apoptotic cells by phagocytes (5-7) . Glucose Neurons were then treated with colchicine (1 ,uM). Deoxyglucose (DG, 2 mM) was added to all cultures 8 hr after colchicine treatment. ATP was measured 9.5 hr after addition of colchicine (1.5 hr after DG); caspase activity and apoptosis were quantitated after 18 hr exposure to colchicine (8.5 hr after DG). As a control, neurons were incubated with colchicine alone. Data from this incubation (see Figs. 1 clearly reversed the inhibition of apoptotic-related morphological features and the inhibition of PS exposure (Fig. SC) .
Control of Apoptosis by ATP due to Translationdependent and Translation-independent Mechanisms Protein synthesis depends on high ATP concentrations, and colchicine-induced apoptosis may require ongoing translation. We found that both cycloheximide (CHX) and actinomycin D (ActD) prevented caspase activation and apoptotic death. The two inhibitors of protein synthesis arrested the neuronal degeneration process at a morphological stage similar to that observed with DG or zVAD-fmk (Fig. 7A) . Pronounced protection from apoptosis by delayed addition of CHX was observed up to about 10 hr after colchicine addition. As shown in Figure 7B, (1 ,uM) . GSNO (100 ,uM) or MPP+ (50 ,uM) was added to the cultures 8 hr after colchicine. ATP was measured 9.5 hr after addition of colchicine (1.5 hr after MPP+/ GSNO); caspase activity and apoptosis were quantitated after 18 hr exposure to colchicine (8.5 hr after MPP+/GSNO). As a control, neurons were incubated with colchicine alone. Data from this incubation (see Fig. 4 ) were used as 100% reference values. All data shown are expressed as percentage of colchicinealone values and are means from three different experiments. (B) CGC were incubated in the absence or presence of glucose and of different inhibitors as described above. After 18 hr, cell lysates were prepared and analyzed by Western blot for caspase-3 processing. Recombinant caspase-3 was used as standard.
CHX. The resulting data were compared with the corresponding concentration of either inhibitor required to prevent colchicine-triggered apoptosis (Fig. 7C) . High DG concentrations (.5 mM) were able to completely shut down protein synthesis, and may thus have inhibited apoptosis exclusively by this mechanism. On the other hand, low DG concentrations (iI mM) inhibited apoptosis, although inhibition of translation was minimal (<25%). Such a small extent of translational inhibition did not prevent apoptosis when CHX was used instead. Thus, ATP depletion by DG (1 ,uM (33) (34) (35) (36) . Such defects may have either a genetic basis (37, 38) or be due to metabolic inhibition of oxidative phosphorylation, for instance, by nitric oxide (30, (39) (40) (41) (42) . It is well established that ATP depletion facilitates damage by many stimuli and sensitizes neurons, particularly to excitotoxicity (34, 43) . In extreme cases, ATP depletion itself may be the main trigger for subsequent neuronal damage (22 (30) . It has been argued that in some cell types, NO donors may directly affect caspases, and therefore prevent apoptosis (48, 49) . However, this is not the case in CGC exposed to GSNO (18) . As shown in the present study, the prevention of caspase activation and apoptosis by NO donors can be explained by their ability to deplete ATP, since the effects of GSNO on apoptosis were easily reversed by glucose. The execution of several, currently known apoptotic degradation processes can procede in the absence of ATP. For instance, nuclear condensation, PS exposure, protease activities, and DNAse activities themselves do not require energy. However, one central step upstream of these activities is the activation of execution caspases within the so-called apoptosome complex. In vitro, reconstitution of this complex is only possible in the presence of ATP or dATP (12, 13) , and depletion of ATP by 50-70% in living cells prevents caspase activation (14, 15, 30) . Conversely, glucose supplementation restores caspase activation and the apoptotic phenotype. Thus, inhibition of caspase activation at the level of the apoptosome is a plausible mechanism, which can explain the effects of ATP depletion observed in our system. Accordingly, we found that procaspases-3 and 7 were not processed in ATP-depleted neurons.
In addition to the apoptosome complex, a second target that is influenced by ATP depletion involves translation-dependent processes. In several nonexcitotoxic models of programmed neuronal death [e.g., growth factor withdrawal, potassium deprivation (50, 51) Intraventricular colchicine injection in the brain is a well-characterized inducer of neuronal stress (52) and stress responses (53) . In addition to microtubule depolymerization and cell cycle arrest, colchicine triggers apoptosis in many tumor cells (54) as well as in postmitotic CGC in vitro (18, 20) and in vivo (19) . Exposure of CGC to colchicine has several secondary effects, such as induction of NO synthase, fos-expression, and disturbance of Ca2+ homeostasis, all of which precede typical apoptotic processes, such as DNA fragmentation, activation of caspases, and cleavage of fodrin (20, 18, 22) . Our present findings show that caspase activation and the subsequent apoptotic events are strictly dependent on microtubule depolymerization itself. This is suggested by the comparable effects of colchicine and nocodazol, which are chemically unrelated but cause microtubule disruption. In addition, block of microtubule depolymerization by taxol, which functionally antagonizes colchicine, prevented caspase activation and apoptosis. This confirms earlier suggestions that microtubule integrity may indeed be one of the general sensors important for the control of the cell death machinery (20, 55) . Recent data showing an effect of microtubule disruption on mitochondrial permeability transition (56) and on the phosphorylation state of Bcl-2 (55,57) suggest a link between microtubule integrity and suppression of caspase-activating mechanisms.
Although caspase inhibitors did not prevent microtubule breakdown and the loss of neuronal projections, the somata remained viable (as analyzed by MTT reduction, leucine incorporation, and calcein retention) for .36 hr. Thereafter, neurons started to die slowly with features that differed morphologically from those of classical apotosis. These cells, while undergoing some kind of nuclear condensation and chromatin margination (as observed in pre-apoptotic stages), did not expose phosphatidylserine on the outer surface (data not shown) and underwent late cell lysis. This is consistent with previous observations that caspase inhibition can block apoptosis, but not entirely prevent delayed cell death (14, 30, 58, 59) . Thus, our findings suggest that inhibition of caspases can explain the uncoupling of degenerative processes in neuronal projections from the eventual death of the cell. In particular, the observation that caspase inhibition hinders PS exposure but does not prevent late cell lysis raises the question as to whether pharmacological inhibition of caspases is always desirable in in vivo neurodegenerative conditions. Inhibition of caspases by synthetic peptides, as well as prevention of caspase activation because of a concomitant energy deprivation, would allow the persistence and late dissolution of severely damaged cells (57) . Such conditions may foster the onset of inflammatory responses and a progression of disease.
